Cephapirin: Difference between revisions
No edit summary |
m Protected "Cephapirin": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)) |
||
(One intermediate revision by one other user not shown) | |||
Line 58: | Line 58: | ||
}} | }} | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{SI}} | ||
{{ | {{CMG}} | ||
==Overview== | ==Overview== |
Latest revision as of 18:53, 18 August 2015
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
MedlinePlus | a601206 |
Pregnancy category |
|
Routes of administration | Intravenous, intramuscular |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C17H17N3O6S2 |
Molar mass | 423.466 g/mol |
3D model (JSmol) | |
| |
| |
(verify) |
WikiDoc Resources for Cephapirin |
Articles |
---|
Most recent articles on Cephapirin |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Cephapirin at Clinical Trials.gov Clinical Trials on Cephapirin at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Cephapirin
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Cephapirin Discussion groups on Cephapirin Patient Handouts on Cephapirin Directions to Hospitals Treating Cephapirin Risk calculators and risk factors for Cephapirin
|
Healthcare Provider Resources |
Causes & Risk Factors for Cephapirin |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Cefapirin (INN, also spelled cephapirin) is an injectable, first-generation cephalosporin antibiotic. It is marketed under the trade name Cefadyl. Production for use in humans has been discontinued in the United States.[1]
It also has a role in veterinary medicine as Metricure, an intrauterine preparation, and combined with prednisolone in Mastiplan, an intramammary preparation. Both are licenced in cattle.